vs
Side-by-side financial comparison of GERON CORP (GERN) and LandBridge Co LLC (LB). Click either name above to swap in a different company.
LandBridge Co LLC is the larger business by last-quarter revenue ($56.8M vs $47.2M, roughly 1.2× GERON CORP). LandBridge Co LLC runs the higher net margin — 14.2% vs -39.0%, a 53.2% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 55.6%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 72.8%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
GERN vs LB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $56.8M |
| Net Profit | $-18.4M | $8.1M |
| Gross Margin | — | — |
| Operating Margin | -29.4% | 60.0% |
| Net Margin | -39.0% | 14.2% |
| Revenue YoY | 67.1% | 55.6% |
| Net Profit YoY | 30.3% | -83.7% |
| EPS (diluted) | $-0.03 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $56.8M | ||
| Q3 25 | $47.2M | $50.8M | ||
| Q2 25 | $49.0M | $47.5M | ||
| Q1 25 | $39.6M | $44.0M | ||
| Q4 24 | — | $36.5M | ||
| Q3 24 | $28.3M | $28.5M | ||
| Q2 24 | $882.0K | $26.0M | ||
| Q1 24 | $304.0K | $19.0M |
| Q4 25 | — | $8.1M | ||
| Q3 25 | $-18.4M | $8.1M | ||
| Q2 25 | $-16.4M | $7.5M | ||
| Q1 25 | $-19.8M | $6.5M | ||
| Q4 24 | — | $49.3M | ||
| Q3 24 | $-26.4M | $2.7M | ||
| Q2 24 | $-67.4M | $-57.7M | ||
| Q1 24 | $-55.4M | $10.8M |
| Q4 25 | — | 60.0% | ||
| Q3 25 | -29.4% | 60.8% | ||
| Q2 25 | -25.4% | 60.0% | ||
| Q1 25 | -42.2% | 57.0% | ||
| Q4 24 | — | 49.4% | ||
| Q3 24 | -99.8% | 11.2% | ||
| Q2 24 | -7860.9% | -197.4% | ||
| Q1 24 | -18465.1% | 71.1% |
| Q4 25 | — | 14.2% | ||
| Q3 25 | -39.0% | 15.9% | ||
| Q2 25 | -33.4% | 15.8% | ||
| Q1 25 | -50.1% | 14.7% | ||
| Q4 24 | — | 135.2% | ||
| Q3 24 | -93.5% | 9.3% | ||
| Q2 24 | -7639.8% | -222.1% | ||
| Q1 24 | -18220.4% | 56.7% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | $-0.03 | $0.26 | ||
| Q2 25 | $-0.02 | $0.24 | ||
| Q1 25 | $-0.03 | $0.20 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.04 | $-0.04 | ||
| Q2 24 | $-0.10 | — | ||
| Q1 24 | $-0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | $30.7M |
| Total DebtLower is stronger | — | $570.7M |
| Stockholders' EquityBook value | $248.7M | $340.3M |
| Total Assets | $567.4M | $1.4B |
| Debt / EquityLower = less leverage | — | 1.68× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $30.7M | ||
| Q3 25 | $78.1M | $28.3M | ||
| Q2 25 | $77.7M | $20.3M | ||
| Q1 25 | $83.7M | $14.9M | ||
| Q4 24 | — | $37.0M | ||
| Q3 24 | $60.3M | $14.4M | ||
| Q2 24 | $116.9M | $24.6M | ||
| Q1 24 | $189.8M | — |
| Q4 25 | — | $570.7M | ||
| Q3 25 | — | $366.1M | ||
| Q2 25 | — | $370.9M | ||
| Q1 25 | — | $375.5M | ||
| Q4 24 | — | $385.5M | ||
| Q3 24 | — | $242.4M | ||
| Q2 24 | — | $360.8M | ||
| Q1 24 | — | — |
| Q4 25 | — | $340.3M | ||
| Q3 25 | $248.7M | $272.0M | ||
| Q2 25 | $259.5M | $266.4M | ||
| Q1 25 | $268.2M | $217.0M | ||
| Q4 24 | — | $211.8M | ||
| Q3 24 | $292.3M | $97.2M | ||
| Q2 24 | $306.7M | $296.4M | ||
| Q1 24 | $344.9M | $162.3M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $567.4M | $1.1B | ||
| Q2 25 | $555.2M | $1.1B | ||
| Q1 25 | $562.5M | $1.0B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | $444.9M | $689.9M | ||
| Q2 24 | $449.4M | $710.5M | ||
| Q1 24 | $482.1M | — |
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.35× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.73× | ||
| Q4 24 | — | 1.82× | ||
| Q3 24 | — | 2.49× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | $126.3M |
| Free Cash FlowOCF − Capex | — | $122.0M |
| FCF MarginFCF / Revenue | — | 214.9% |
| Capex IntensityCapex / Revenue | — | 7.5% |
| Cash ConversionOCF / Net Profit | — | 15.68× |
| TTM Free Cash FlowTrailing 4 quarters | — | $207.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $126.3M | ||
| Q3 25 | $-13.6M | $34.9M | ||
| Q2 25 | $-27.4M | $37.3M | ||
| Q1 25 | $-48.0M | $15.9M | ||
| Q4 24 | — | $67.6M | ||
| Q3 24 | $-58.9M | $7.5M | ||
| Q2 24 | $-53.5M | $16.0M | ||
| Q1 24 | $-62.3M | $17.2M |
| Q4 25 | — | $122.0M | ||
| Q3 25 | — | $33.7M | ||
| Q2 25 | — | $36.1M | ||
| Q1 25 | — | $15.8M | ||
| Q4 24 | — | $66.7M | ||
| Q3 24 | — | $7.1M | ||
| Q2 24 | $-53.7M | $15.7M | ||
| Q1 24 | $-62.9M | $17.1M |
| Q4 25 | — | 214.9% | ||
| Q3 25 | — | 66.3% | ||
| Q2 25 | — | 75.9% | ||
| Q1 25 | — | 36.0% | ||
| Q4 24 | — | 182.6% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | -6086.6% | 60.4% | ||
| Q1 24 | -20680.3% | 90.1% |
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | 0.0% | 1.1% | ||
| Q2 24 | 23.4% | 1.4% | ||
| Q1 24 | 202.3% | 0.5% |
| Q4 25 | — | 15.68× | ||
| Q3 25 | — | 4.31× | ||
| Q2 25 | — | 4.98× | ||
| Q1 25 | — | 2.46× | ||
| Q4 24 | — | 1.37× | ||
| Q3 24 | — | 2.80× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
